Alkermes plc. vs Insmed
Alkermes plc. is the larger business, with $1.48bn of revenue in fiscal 2025 against $606m for Insmed (2.4 times as much). Insmed grew faster (66.7% against -5.2%). Alkermes plc. kept more of each dollar of sales as profit: a net margin of 16.4% against -210.5%. Alkermes plc. carries less debt relative to equity (0.0% against 74.0%).
| Latest fiscal year | Alkermes plc.ALKS, 2025 | InsmedINSM, 2025 |
|---|---|---|
| Revenue | $1.48bn | $606m |
| Revenue growth | -5.2% | 66.7% |
| Net income | $242m | −$1.28bn |
| Operating margin | 17.2% | -205.6% |
| Net margin | 16.4% | -210.5% |
| Return on equity | 14.7% | — |
| Free cash flow | $480m | −$968m |
| Cash | $389m | $510m |
| Total debt | $0 | $547m |
| Debt to equity | 0.0% | 74.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 2,050 | 1,664 |
| Market value | $7.84bn | $23.17bn |
| Price vs our value range | Within our value range | — |
| Moat score | 63 (Moderate) | 24 (Weak) |
| Insider trades, 12 months | 0 buys, 33 sales | 0 buys, 169 sales |